Marshall Islands vs New Zealand: Proportion of the target population who received a 3rd dose of
Marshall Islands
62.0%
in 2024
New Zealand
60.0%
in 2024
Marshall Islands rank
141st
New Zealand rank
143rd
Proportion of the target population who received a 3rd dose of over time
- Marshall Islands
- New Zealand
How they compare
Marshall Islands currently reports 62.0% against 60.0% in New Zealand, a difference of 2.0%.
The two have swapped places 1 time across 16 shared years of data; in 2009 it was New Zealand ahead.
Marshall Islands ranks 141st and New Zealand ranks 143rd of 157 countries.
New Zealand has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Marshall Islands | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 49.0% | 87.0% | 38.0% | New Zealand |
| 2010s | 51.4% | 92.6% | 41.2% | New Zealand |
| 2020s | 50.4% | 81.2% | 30.8% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Marshall Islands or New Zealand?
- Marshall Islands, at 62.0% against 60.0% in New Zealand as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Marshall Islands and New Zealand?
- 2.0%, with Marshall Islands ahead.
- How many years of comparable data are there for Marshall Islands and New Zealand?
- 16 years are reported by both, from 2009 to 2024.
- How do Marshall Islands and New Zealand rank globally for proportion of the target population who received a 3rd dose of?
- Marshall Islands ranks 141st and New Zealand ranks 143rd of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.